{"schema_version":"secwatch.filing_event.v1","accession":"0001641489-25-000003","form_type":"8-K","ticker":"VTVT","cik":"0001641489","company_name":"vTv Therapeutics Inc.","filed_at":"2025-01-13T23:59:59+00:00","discovered_at":"2026-05-14T18:03:04.276438+00:00","generated_at":"2026-05-28T03:29:00.742703+00:00","sec_items":["7.01","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"low","headline":"vTv Therapeutics posts updated investor presentation for January 2025","bullets":["Company posted an updated slide presentation on its website on Jan 13, 2025.","Presentation focuses on improving lives of people with Type 1 Diabetes.","No specific financial, pipeline, or regulatory updates disclosed in excerpt."],"urls":{"canonical":"https://secwatch.observer/filing/0001641489-25-000003","json":"https://secwatch.observer/filing/0001641489-25-000003.json","markdown":"https://secwatch.observer/filing/0001641489-25-000003.md","text":"https://secwatch.observer/filing/0001641489-25-000003.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1641489/000164148925000003/0001641489-25-000003-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1641489/000164148925000003/vtvt-20250113.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-28T03:29:00.742703+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}